Médica Sur, S.A.B. de C.V. (MEDICAB.MX)
MXN 33.7
(1.02%)
MXN 33.7
(1.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 423.87 Million | 270.09 Million | 821.32 Million | 1.1 Billion | 425.44 Million | 305.89 Million |
| Net Income | 634.98 Million | 949.8 Million | 1.15 Billion | 558.85 Million | 140.56 Million | 169.35 Million |
| Depreciation & Amortization | 178.61 Million | 169.26 Million | 277.37 Million | 323.76 Million | 350.86 Million | 225.18 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -55.74 Million | -294.38 Million | 36.21 Million | -65.25 Million | 4.37 Million | -34.27 Million |
| Other non-cash items | -18.47 Million | -554.59 Million | -646.75 Million | 283.95 Million | -70.37 Million | -54.36 Million |
| Investing Cash Flow | 234.17 Million | 732.84 Million | 2.55 Billion | -112.61 Million | -332.16 Million | -23.67 Million |
| Investments in PPE | -213.63 Million | -186.45 Million | -150.79 Million | -128.51 Million | -137.33 Million | -179.9 Million |
| Acquisitions | 126.5 Million | 744.99 Million | 2.35 Billion | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 5.3 Million | -12.14 Million | 355.2 Million | 15.89 Million | -194.82 Million | 156.22 Million |
| Financing Cash Flow | -1.17 Billion | -3.31 Billion | -421.59 Million | -693.08 Million | 12.58 Million | -327.55 Million |
| Debt repayment | - | - | - | -1.53 Billion | -132.56 Million | -832.56 Million |
| Dividends payments | -659.25 Million | -3.01 Billion | -161.68 Million | -185.75 Thousand | -1.22 Million | -72.98 Million |
| Common Stock Repurchased | -429.07 Million | -206.22 Million | -80.45 Million | -230.6 Million | -2.05 Million | - |
| Common Stock Issuance | - | - | - | 4900.00 | - | - |
| Other Financing Activities | -86.37 Million | -87.2 Million | -179.45 Million | 1.07 Billion | 148.43 Million | 578 Million |
| Accounts receivables | -95.69 Million | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -3.2 Million | -8.66 Million | 28.59 Million | -52.85 Million | -73.39 Thousand | 31.38 Million |
| Other working capital | 43.15 Million | -285.72 Million | 7.61 Million | -12.4 Million | 4.45 Million | -65.65 Million |
| Cash at beginning of period | 1.22 Billion | 3.53 Billion | 572.84 Million | 277.22 Million | 171.36 Million | 216.69 Million |
| Cash at end of period | 704.74 Million | 1.22 Billion | 3.53 Billion | 572.84 Million | 277.22 Million | 171.36 Million |
| Capital Expenditure | -213.63 Million | -186.45 Million | -150.79 Million | -128.51 Million | -137.33 Million | -179.9 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -516.65 Million | -2.31 Billion | 2.95 Billion | 295.61 Million | 105.86 Million | -45.33 Million |
| Free Cash Flow | 210.23 Million | 83.63 Million | 670.52 Million | 972.8 Million | 288.1 Million | 125.99 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 122.18 Million | 82.43 Million | 121.91 Million | 634.98 Million | 160.16 Million | 200.67 Million |
| Depreciation & Amortization | 50.97 Million | 46.87 Million | 45.86 Million | 178.61 Million | 48.41 Million | 44.6 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 41.18 Million | 10.89 Million | 65.24 Million | -55.74 Million | -41.76 Million | -36.38 Million |
| Other non-cash items | -3.38 Million | -38.06 Million | 2.41 Million | -18.47 Million | 11.87 Million | -60.2 Million |
| Investing Cash Flow | 8.03 Million | 46.34 Million | -53.95 Million | 234.17 Million | 207.39 Million | 72.37 Million |
| Investments in PPE | -21.06 Million | -33.88 Million | -53.11 Million | -213.63 Million | -37.65 Million | -66.26 Million |
| Acquisitions | - | 50 Million | - | 126.5 Million | 124.31 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 29.09 Million | 124 Thousand | -16.99 Million | 5.3 Million | 9.86 Million | 138.64 Million |
| Financing Cash Flow | -7.11 Million | -141.54 Million | -11.95 Million | -1.17 Billion | -200.86 Million | -57.3 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -3.05 Million | -137.28 Million | -8.05 Million | -659.25 Million | -4.23 Million | -18.76 Million |
| Common Stock Repurchased | - | - | - | -429.07 Million | -121.71 Million | -34.61 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.05 Million | -4.25 Million | - | - | - | -3.92 Million |
| Accounts receivables | 65.41 Million | -25.98 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 11.31 Million | -3.13 Million | 14.43 Million | -3.2 Million | -2.05 Million | 3.28 Million |
| Other working capital | -35.53 Million | 40.01 Million | - | - | - | -39.67 Million |
| Cash at beginning of period | 761.69 Million | 825.56 Million | 704.74 Million | 1.22 Billion | 670.76 Million | 507 Million |
| Cash at end of period | 973.57 Million | 761.69 Million | 825.56 Million | 704.74 Million | 704.74 Million | 670.76 Million |
| Capital Expenditure | -21.06 Million | -33.88 Million | -53.11 Million | -213.63 Million | -37.65 Million | -66.26 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 211.88 Million | -63.86 Million | 120.81 Million | -516.65 Million | 33.97 Million | 163.76 Million |
| Free Cash Flow | 189.89 Million | -2.54 Million | 133.61 Million | 210.23 Million | -10.21 Million | 82.43 Million |
1419
0LB2
SPMMF
4575
RGR
0KEJ